Mr. Brian Di Donato notified Immunocore Holdings plc (the “Company”) of his decision to resign as Executive Vice President, Chief Financial Officer and Head of Strategy and principal financial officer of the Company, effective December 31, 2024, to pursue another opportunity.
On August 23, 2024 , Monica Sparks notified Banc of California, Inc. (the “Company”) and Banc of California (the “Bank”), a wholly owned subsidiary of the Company, of her decision to resign as Executive Vice President, Chief Accounting Officer of the Company and the Bank.
Departed
Michael Mason
Executive Vice President, Chief Financial Officer and Treasurer
On August 26, 2024, Michael Mason notified Karyopharm Therapeutics Inc. (the “Company”) of his intention to resign as the Company’s Executive Vice President, Chief Financial Officer and Treasurer to pursue other professional interests.
Departed
William E. Shea
Senior Vice President, Treasurer and Chief Financial Officer
On August 22, 2024, Shara Pathak resigned as a member of the Board of Directors of the registrant (“Laser Photonics”) without any disagreement regarding the operations, policies or practices of Laser Photonics.
On August 26, 2024, Charles R. Patton, a member of the Board of Directors (the “Board”) of Sterling Infrastructure, Inc. (the “Company”), notified the Company of his intention to retire from the Board and as a member of each of the Compensation and Talent Development Committee and the Corporate Governance and Nominating Committee, effective September 1, 2024.
On August 27, 2024, Hilliard M. Eure III resigned as a member of the Board of Directors (the “Board”) of MarineMax, Inc. (the “Company”), effective September 1, 2024.
Departed
Michael J. Berry
Executive Vice President and Chief Financial Officer
On August 22, 2024, Michael J. Berry informed the Company of his decision to transition from his role of Executive Vice President and Chief Financial Officer by May 23, 2025.
On August 26, 2024, David L. Lucchino, a member of our Board of Directors, or the Board, notified us that he resigned from the Board, effective immediately.
On August 28, 2024, the Company announced that Amy Weaver will step down from her role as President and Chief Financial Officer of the Company effective upon the appointment of her successor or upon the filing of the Company’s annual report on Form 10-K for the fiscal year ending January 31, 2025 (the “10-K Filing Date”), if earlier.
On August 28, 2024, the Company announced that effective as of August 28, 2024, Gregory S. Levin would no longer serve as the Company’s Chief Executive Officer and President or as a member of the Board.
On August 26, 2024, Melissa Goldman notified the Ally Financial Inc. ( Ally ) Board of Directors of her intention to resign as a director of Ally, effective on August 27, 2024.
Departed
Danelle Barrett
Director
ShoulderUP Technology Acquisition Corp.
Effective
2024-08-26
Filed
August 28, 2024, 7:59 PM ET
It is with deep sorrow that ShoulderUp Technology Acquisition Corp. (the “Company”) announces the unexpected passing of Danelle Barrett, a valued member of its Board of Directors, on August 26, 2024.
Departed
J. Tyler Opel
director
AmeriCann, Inc.
Effective
2024-08-23
Filed
August 28, 2024, 7:59 PM ET
On August 23, 2024 J. Tyler Opel stepped down as a director of the Company.
On August 26, 2024, Blake Johnson notified Two Harbors Investment Corp. (the “Company”) of his intention to resign from his position as Acting Chief Accounting Officer of the Company, effective no later than October 25, 2024
Jared Demark, having provided notice of his resignation, shall cease serving as chief executive officer (principal executive officer) of CoinShares Co. (the “Sponsor”).
Departed
Blaise Coleman
President and Chief Executive Officer
Endo LP
Effective
2024-08-29
Successor
Scott Hirsch
Filed
August 27, 2024, 7:59 PM ET
On August 25, 2024, the Board of Directors (the “Board”) of Endo, Inc. (the “Company”) determined that Blaise Coleman will no longer serve as the Company’s President and Chief Executive Officer, effective August 29, 2024.
Departed
Douglas S. Sharp
Executive Vice President of Finance, Chief Financial Officer and Treasurer
On August 21, 2024, Grace Johnston, Ph.D. delivered her resignation as the Chief Commercial Officer of Quantum-Si Incorporated (the “Company”), effective as of September 6, 2024.
Departed
Kristi Jones
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
Kristi Jones
Chief Executive Officer
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
Departed
Leena Gandhi
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
Sol J. Barer
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
Alan S. Roemer
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
Grant Verstandig
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
Zhengbin (Bing) Yao
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
Tim Bertram
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
(interim)
Albert N. Marchio II
Interim Chief Financial Officer
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
Departed
Mathias Oelke
Chief Scientific Officer
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
Departed
Paul D'Angio
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Patrick C. Graney III, a member of the Board of Directors (the “Board”) of Truist Financial Corporation (“Truist”), notified Truist of his decision to retire from the Board effective August 31, 2024.
On August 21, 2024, Mr. Bonaccorso notified Verrica Pharmaceuticals Inc. (the “Company”) that he will resign from his position as Chief Commercial Officer of the Company, effective August 30, 2024.
On August 21, 2024, Mr. Don Kalkofen tendered his resignation as Chief Financial Officer of Alpha Cognition Inc. (the “Company”), effective October 1, 2024.
On August 26, 2024, Johnson & Johnson (the Company) issued a press release announcing that Peter M. Fasolo, Executive Vice President, Chief Human Resources Officer (CHRO), has elected to retire.
Departed
Richard K. Coleman, Jr.
Director
STAR EQUITY HOLDINGS, INC.
Filed
August 26, 2024, 7:59 PM ET
On August 26, 2024, Star Equity Holdings, Inc. (the “Company”) determined that Richard K. Coleman, Jr. will not stand for reelection as a director of the Company at the Company’s 2024 Annual Stockholder Meeting.
Departed
Michael A. Cunnion
Director
STAR EQUITY HOLDINGS, INC.
Filed
August 26, 2024, 7:59 PM ET
On August 26, 2024, Michael A. Cunnion notified the Company of his decision not to stand for reelection as a director of the Company at the Company’s 2024 Annual Stockholder Meeting, to permit him to focus his time and energy on other business ventures.
Departed
John W. Sayward
Director
STAR EQUITY HOLDINGS, INC.
Filed
August 26, 2024, 7:59 PM ET
On August 26, 2024, John W. Sayward notified the Company of his decision not to stand for reelection as a director of the Company at the Company’s 2024 Annual Stockholder Meeting, to permit him to focus his time and energy on other business ventures.
On August 23, 2024, Erin Brockovich, a member of the Board of Directors (the “Board”) of LifeVantage Corporation (the “Company”), notified the Company of her resignation as a member of the Board and any committees of the Board, effective August 26, 2024.
Departed
Jeroen Decleer
Senior Vice President and President of Off-Highway Drive and Motion Systems
W. Bryan Buckler’s notification to the Company on August 20, 2024 of his decision to resign his position as Chief Financial Officer of OGE Energy and OG&E effective August 29, 2024.
Departure of Stephan D. Scholl as Chief Executive Officer and as a Member of the Board
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.